Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study

Sebastian Goebel, Juergen H. Prochaska, Lisa Eggebrecht, Ronja Schmitz, Claus Juenger, Heidrun Lamparter, Markus Nagler, Karsten Keller, Meike Coldewey, Sven-Oliver Troebs, Simon Diestelmeier, Soeren Schwuchow-Thonke, Christoph Bickel, Michael Lauterbach, Karl J. Lackner, Hugo ten Cate, Thomas Muenzel, Roland Hardt, Philipp S. Wild*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1930-1939
Number of pages10
JournalThrombosis and Haemostasis
Volume118
Issue number11
DOIs
Publication statusPublished - Nov 2018

Keywords

  • heart failure
  • oral anti-coagulation
  • clinical outcome
  • quality of care
  • health care model
  • THERAPY ANTITHROMBOTIC THERAPY
  • CLINICAL-PRACTICE GUIDELINES
  • ED AMERICAN-COLLEGE
  • ATRIAL-FIBRILLATION
  • ANTICOAGULANT-THERAPY
  • EJECTION FRACTION
  • ADVERSE EVENTS
  • SINUS RHYTHM
  • WARFARIN
  • OUTCOMES

Cite this

Goebel, S., Prochaska, J. H., Eggebrecht, L., Schmitz, R., Juenger, C., Lamparter, H., Nagler, M., Keller, K., Coldewey, M., Troebs, S-O., Diestelmeier, S., Schwuchow-Thonke, S., Bickel, C., Lauterbach, M., Lackner, K. J., ten Cate, H., Muenzel, T., Hardt, R., & Wild, P. S. (2018). Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study. Thrombosis and Haemostasis, 118(11), 1930-1939. https://doi.org/10.1055/s-0038-1673380